Financial Distress, Use of Cost-Coping Strategies, and Adherence to Prescription Medication Among Patients With Cancer-Reference-Cited by-同舟云学术

Financial Distress, Use of Cost-Coping Strategies, and Adherence to Prescription Medication Among Patients With Cancer

Published:2013-11 Issue:6S Volume:9 Page:60s-63s
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Zullig Leah L.¹,Peppercorn Jeffrey M.¹,Schrag Deborah¹,Taylor Donald H.¹,Lu Ying¹,Samsa Gregory¹,Abernethy Amy P.¹,Zafar S. Yousuf¹

Affiliation:

1. University of North Carolina, Chapel Hill; Durham Veterans Affairs Medical Center; Duke Cancer Institute; Duke Clinical Research Institute; Duke University, Durham, NC; and Dana-Farber Cancer Institute, Boston, MA

Abstract

The authors found that cost-related medication nonadherence was prevalent among patients with cancer who sought financial assistance.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2013.000971

Reference9 articles.

1. Projections of the Cost of Cancer Care in the United States: 2010-2020

2. National Estimates of Out-of-Pocket Health Care Expenditure Burdens Among Nonelderly Adults With Cancer: 2001 to 2008

3. A Copay Foundation Assistance Support Program for Patients Receiving Intravenous Cancer Therapy

4. Affordable Care Act Reforms Could Reduce The Number Of Underinsured US Adults By 70 Percent

5. Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonadherence to oral cancer chemotherapy in hepatocellular carcinoma: prevalence and predictive factors in Vietnam;BMC Cancer;2024-07-15

2. An assessment of the direct and indirect costs of breast cancer treatment in leading cancer hospitals in Ghana;PLOS ONE;2024-05-21

3. Pharmacy Assistance Programs for Oral Anticancer Drugs: A Narrative Review;JCO Oncology Practice;2024-04

4. Health insurance as a moderator in the relationship between financial toxicity and medical cost‐coping behaviors: Evidence from patients with lung cancer in China;Cancer Medicine;2024-01

5. Perspectives on the Cost and Value of Stem Cell and Emerging Therapies;Comprehensive Hematology and Stem Cell Research;2024